Cargando…
siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells
The outbreak of severe acute respiratory syndrome (SARS) in 2002–2003 has had a significant impact worldwide. No effective prophylaxis or treatment for SARS is available up to now. Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for SARS-associated coronavirus (SARS-CoV). By expressi...
Autores principales: | Lu, C.-Y., Huang, H.-Y., Yang, T.-H., Chang, L.-Y., Lee, C.-Y., Huang, L.-M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088151/ https://www.ncbi.nlm.nih.gov/pubmed/18449585 http://dx.doi.org/10.1007/s10096-008-0495-5 |
Ejemplares similares
-
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome
por: Imai, Y., et al.
Publicado: (2007) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2
por: Welch, Jennifer L, et al.
Publicado: (2021) -
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
por: Li, T, et al.
Publicado: (2005) -
siRNA Versus miRNA as Therapeutics for Gene Silencing
por: Lam, Jenny K W, et al.
Publicado: (2015)